Cargando…

Clinical application of MR-Linac in tumor radiotherapy: a systematic review

Recent years have seen both a fresh knowledge of cancer and impressive advancements in its treatment. However, the clinical treatment paradigm of cancer is still difficult to implement in the twenty-first century due to the rise in its prevalence. Radiotherapy (RT) is a crucial component of cancer t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xin, Li, Zhenjiang, Yin, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015924/
https://www.ncbi.nlm.nih.gov/pubmed/36918884
http://dx.doi.org/10.1186/s13014-023-02221-8
_version_ 1784907302165282816
author Liu, Xin
Li, Zhenjiang
Yin, Yong
author_facet Liu, Xin
Li, Zhenjiang
Yin, Yong
author_sort Liu, Xin
collection PubMed
description Recent years have seen both a fresh knowledge of cancer and impressive advancements in its treatment. However, the clinical treatment paradigm of cancer is still difficult to implement in the twenty-first century due to the rise in its prevalence. Radiotherapy (RT) is a crucial component of cancer treatment that is helpful for almost all cancer types. The accuracy of RT dosage delivery is increasing as a result of the quick development of computer and imaging technology. The use of image-guided radiation (IGRT) has improved cancer outcomes and decreased toxicity. Online adaptive radiotherapy will be made possible by magnetic resonance imaging-guided radiotherapy (MRgRT) using a magnetic resonance linear accelerator (MR-Linac), which will enhance the visibility of malignancies. This review's objectives are to examine the benefits of MR-Linac as a treatment approach from the perspective of various cancer patients' prognoses and to suggest prospective development areas for additional study.
format Online
Article
Text
id pubmed-10015924
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100159242023-03-16 Clinical application of MR-Linac in tumor radiotherapy: a systematic review Liu, Xin Li, Zhenjiang Yin, Yong Radiat Oncol Review Recent years have seen both a fresh knowledge of cancer and impressive advancements in its treatment. However, the clinical treatment paradigm of cancer is still difficult to implement in the twenty-first century due to the rise in its prevalence. Radiotherapy (RT) is a crucial component of cancer treatment that is helpful for almost all cancer types. The accuracy of RT dosage delivery is increasing as a result of the quick development of computer and imaging technology. The use of image-guided radiation (IGRT) has improved cancer outcomes and decreased toxicity. Online adaptive radiotherapy will be made possible by magnetic resonance imaging-guided radiotherapy (MRgRT) using a magnetic resonance linear accelerator (MR-Linac), which will enhance the visibility of malignancies. This review's objectives are to examine the benefits of MR-Linac as a treatment approach from the perspective of various cancer patients' prognoses and to suggest prospective development areas for additional study. BioMed Central 2023-03-14 /pmc/articles/PMC10015924/ /pubmed/36918884 http://dx.doi.org/10.1186/s13014-023-02221-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Liu, Xin
Li, Zhenjiang
Yin, Yong
Clinical application of MR-Linac in tumor radiotherapy: a systematic review
title Clinical application of MR-Linac in tumor radiotherapy: a systematic review
title_full Clinical application of MR-Linac in tumor radiotherapy: a systematic review
title_fullStr Clinical application of MR-Linac in tumor radiotherapy: a systematic review
title_full_unstemmed Clinical application of MR-Linac in tumor radiotherapy: a systematic review
title_short Clinical application of MR-Linac in tumor radiotherapy: a systematic review
title_sort clinical application of mr-linac in tumor radiotherapy: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015924/
https://www.ncbi.nlm.nih.gov/pubmed/36918884
http://dx.doi.org/10.1186/s13014-023-02221-8
work_keys_str_mv AT liuxin clinicalapplicationofmrlinacintumorradiotherapyasystematicreview
AT lizhenjiang clinicalapplicationofmrlinacintumorradiotherapyasystematicreview
AT yinyong clinicalapplicationofmrlinacintumorradiotherapyasystematicreview